Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Breast Cancer Research

Study Title:  A Phase 3, Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastaic or Locally Advanced Unresectable BRCA-associated Breast Cancer (Identifier: NCT02163694)

Study Purpose:  The purpose of the study is to evaluate the efficacy and tolerability of veliparib/placebo in combination with carboplatin and paclitaxel in HER2-negative metastatic or locally advanced, unresectable, BRCA-associated breast cancer.

Principal Investigator: Cherian Verghese, M.D.

Study Coordinator: Stephanie Smiddy, RN for more information, please contact 419.383.6794.




Last Updated: 8/11/15